Vivos Therapeutics Reports Second Quarter 2023 Financial Results and Provides Operational Update
16. August 2023 16:05 ET
|
Vivos Therapeutics, Inc
Operating Expenses Decreased 31% Quarter Over Quarter and 25% Year to Date,Reflecting Cost Cutting Initiatives Management to Host Conference Call Today at 6:00 pm ET LITTLETON, Colo., Aug. 16,...
Vivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference Call
16. August 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics to Reschedule Second Quarter 2023 Financial Results Conference Call
14. August 2023 17:06 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics Schedules Release of Second Quarter 2023 Financial Results and Conference Call
10. August 2023 20:31 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics Reports First Quarter 2023 Financial Results and Provides Operational Update
08. Juni 2023 16:05 ET
|
Vivos Therapeutics, Inc
Revenue increased 6% Year-Over-Year; Operating Expenses Decreased 20% as Cost Cutting Initiatives Take Hold Management to Host Conference Call Today at 5:00 pm ET LITTLETON, Colo., June 08, 2023 ...
Vivos Therapeutics Schedules Release of First Quarter 2023 Financial Results and Conference Call
06. Juni 2023 16:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., June 06, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics Announces Additional Strategic Initiatives Aimed at Accelerating Anticipated Timeline for Cash Flow Positive Operations
09. Mai 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., May 09, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos”, “the Company”) (NASDAQ:VVOS) today announced it has implemented a broad set of initiatives aimed at improving...
Clinical Study Shows 92% of Patients Report Resolution of Migraine Headaches Using Vivos’ POD® Appliance Treatment
01. Mai 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., May 01, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Operational Update
30. März 2023 16:05 ET
|
Vivos Therapeutics, Inc
2022 and Early 2023 Accomplishments, Including Capital Raise, Cost Reductions and New Technology Acquisition, Set the Stage for Potential 2023 Revenue Growth Management to Host Conference Call...
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2022 Financial Results and Conference Call
30. März 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETOWN, Colo., March 30, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical device and technology company that delivers training and a full...